449 related articles for article (PubMed ID: 34856955)
21. Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis.
Jin W; Zhang H; Li M; Lin S
Cancer Biother Radiopharm; 2023 Mar; 38(2):122-131. PubMed ID: 32614615
[No Abstract] [Full Text] [Related]
22. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b.
Zhang X; Gu G; Li X; Zhang C
Cell Cycle; 2020 Oct; 19(19):2530-2537. PubMed ID: 32892697
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
24. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
25. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
26. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
Cancer Lett; 2019 Sep; 459():122-134. PubMed ID: 31173853
[TBL] [Abstract][Full Text] [Related]
27. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
Han S; Han B; Li Z; Sun D
Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
[TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
30. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
[TBL] [Abstract][Full Text] [Related]
31. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression.
Yang X; Zhao Q; Yin H; Lei X; Gan R
J Drug Target; 2017 Aug; 25(7):653-660. PubMed ID: 28436711
[TBL] [Abstract][Full Text] [Related]
32. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
33. Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling.
Wang S; Ping M; Song B; Guo Y; Li Y; Jia J
Yonsei Med J; 2020 Sep; 61(9):750-761. PubMed ID: 32882759
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
35. miR-491 inhibits BGC-823 cell migration via targeting HMGA2.
Liu Z; Lü Y; Jiang Q; Yang Y; Dang C; Sun R
Int J Biol Markers; 2019 Dec; 34(4):364-372. PubMed ID: 31668113
[TBL] [Abstract][Full Text] [Related]
36. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
37. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
38. Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer.
Zhang Y; Li M; Hu C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):457-464. PubMed ID: 30458987
[TBL] [Abstract][Full Text] [Related]
39. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
Lu C; Shan Z; Li C; Yang L
Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
[TBL] [Abstract][Full Text] [Related]
40. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]